1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

19Dec/11

Chronic Acyclovir-Resistant HSV-2 Ulcer in an Immunosuppressed Patient Treated … – Archives of Dermatology

December 19, 2011Other Transplantationadmin

Chronic Acyclovir-Resistant HSV-2 Ulcer in an Immunosuppressed Patient Treated …Archives of DermatologyA 66-year-old man with mantle cell lymphoma, status post allogeneic stem cell transplant (SCT), presented with a nonhealing perianal ulcer positive…

19Dec/11

Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS – Archives of Dermatology

December 19, 2011Immunosuppressive Drugsadmin

Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESSArchives of Dermatology2 Oral corticosteroid treatment is often proposed for severe DRESS, but oral corticosteroids might favor a relapsing course of the syndrome. Some researchers, 3-4 b…

19Dec/11

One organ donor can save the lives of six people – AMA – Cowra Community News

December 19, 2011Organ Donoradmin

One organ donor can save the lives of six people – AMACowra Community NewsTHE Australian medical Association (AMA) is urging people to use the Christmas holiday period to consider registering to become an organ donor. AMA vice-president, Geoffrey Dob…

19Dec/11

FDA Adds New Warnings to Dronedarone (Multaq) Label – Forbes

December 19, 2011Organ Failureadmin

AFPFDA Adds New Warnings to Dronedarone (Multaq) LabelForbesThe analysis reaffirmed the benefits of dronedarone in ATHENA, finding that dronedarone caused a reduction in hospitalizations and was not associated with an increased risk of cardiovascular d…

19Dec/11

Medicare Penalties For Readmissions Could Be A Tough Hit On Hospitals Serving … – Kaiser Health News

December 19, 2011Organ Failureadmin

Medicare Penalties For Readmissions Could Be A Tough Hit On Hospitals Serving …Kaiser Health NewsHospitals with the highest proportion of poor Medicare patients were nearly three times as likely as others to have substantially high readmission rates …

19Dec/11

Combination Of Vidaza And Donor Lymphocyte Infusions Shows Promise In Relapsed … – The MDS Beacon

December 19, 2011Other Transplantationadmin

Combination Of Vidaza And Donor Lymphocyte Infusions Shows Promise In Relapsed …The MDS BeaconDonor lymphocyte infusion, often abbreviated DLI, is a procedure in which a stem cell transplant patient receives an infusion of donated white blood cells. …

19Dec/11

Rituxan Prolongs HIV-Related Lymphoma Survival – AIDSmeds.com HIV/AIDS Treatment News

December 19, 2011Monoclonal Anti-CD20 Antibodiesadmin

Rituxan Prolongs HIV-Related Lymphoma SurvivalAIDSmeds.com HIV/AIDS Treatment NewsFor people diagnosed with AIDS-related lymphomas, adding Rituxan (rituximab) to standard chemotherapy has a major positive effect on survival, according to new German coh…

19Dec/11

Blood donation camp held at DBHSS – Nagaland Post

December 19, 2011Organ Donoradmin

Blood donation camp held at DBHSSNagaland PostA voluntary blood donation was organized on December 19 at Don Bosco Higher Secondary School (DBHSS), Dimapur by 1 Nagaland girls battalion NCC Kohima led by Lt. Col Joy Choudhury. The awareness camp starte…

19Dec/11

FDA Further Restricts Use of Sanofi's Multaq – Wall Street Journal

December 19, 2011Organ Failureadmin

RTT NewsFDA Further Restricts Use of Sanofi's MultaqWall Street JournalMultaq had world-wide sales of $179 million in the first half of 2011. Early in 2011, the FDA told Sanofi to add to its label that "liver injury, including acute liver fail…

19Dec/11

Presentations Highlight Results of Clinical Data for MLN8237 and VELCADE(R) in … – MarketWatch (press release)

December 19, 2011Monoclonal Anti-CD20 Antibodiesadmin

Presentations Highlight Results of Clinical Data for MLN8237 and VELCADE(R) in …MarketWatch (press release)Also presented were biomarker data from a phase 3 study comparing VELCADE(R) (bortezomib) and rituximab (VcR) to rituximab (R) alone in patient…

Posts navigation

  • « Previous
  • 1
  • …
  • 18,457
  • 18,458
  • 18,459
  • 18,460
  • 18,461
  • …
  • 18,744
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos